ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $478.24 million. The enterprise value is $696.21 million.
Important Dates
The last earnings date was Monday, May 4, 2026, before market open.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 127.19 million shares outstanding. The number of shares has increased by 23.08% in one year.
| Current Share Class | 127.19M |
| Shares Outstanding | 127.19M |
| Shares Change (YoY) | +23.08% |
| Shares Change (QoQ) | -15.39% |
| Owned by Insiders (%) | 5.03% |
| Owned by Institutions (%) | 40.81% |
| Float | 100.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.20 |
| Forward PS | 8.35 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.09
| Current Ratio | 4.09 |
| Quick Ratio | 3.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.73% |
| Return on Invested Capital (ROIC) | -29.71% |
| Return on Capital Employed (ROCE) | -45.82% |
| Weighted Average Cost of Capital (WACC) | 12.02% |
| Revenue Per Employee | $410,233 |
| Profits Per Employee | -$709,788 |
| Employee Count | 193 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 9.00 |
Taxes
In the past 12 months, ADCT has paid $850,000 in taxes.
| Income Tax | 850,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +171.83% in the last 52 weeks. The beta is 1.84, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | +171.83% |
| 50-Day Moving Average | 4.01 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 47.99 |
| Average Volume (20 Days) | 1,139,888 |
Short Selling Information
The latest short interest is 5.14 million, so 4.04% of the outstanding shares have been sold short.
| Short Interest | 5.14M |
| Short Previous Month | 4.29M |
| Short % of Shares Out | 4.04% |
| Short % of Float | 5.12% |
| Short Ratio (days to cover) | 6.10 |
Income Statement
In the last 12 months, ADCT had revenue of $79.18 million and -$136.99 million in losses. Loss per share was -$1.08.
| Revenue | 79.18M |
| Gross Profit | -20.85M |
| Operating Income | -102.58M |
| Pretax Income | -136.14M |
| Net Income | -136.99M |
| EBITDA | -102.04M |
| EBIT | -102.58M |
| Loss Per Share | -$1.08 |
Full Income StatementBalance Sheet
The company has $231.01 million in cash and $436.26 million in debt, with a net cash position of -$205.25 million or -$1.61 per share.
| Cash & Cash Equivalents | 231.01M |
| Total Debt | 436.26M |
| Net Cash | -205.25M |
| Net Cash Per Share | -$1.61 |
| Equity (Book Value) | -216.38M |
| Book Value Per Share | -1.70 |
| Working Capital | 209.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$114.55 million and capital expenditures -$32,000, giving a free cash flow of -$114.58 million.
| Operating Cash Flow | -114.55M |
| Capital Expenditures | -32,000 |
| Depreciation & Amortization | 539,250 |
| Net Borrowing | n/a |
| Free Cash Flow | -114.58M |
| FCF Per Share | -$0.90 |
Full Cash Flow StatementMargins
Gross margin is -26.33%, with operating and profit margins of -129.56% and -173.02%.
| Gross Margin | -26.33% |
| Operating Margin | -129.56% |
| Pretax Margin | -171.95% |
| Profit Margin | -173.02% |
| EBITDA Margin | -128.87% |
| EBIT Margin | -129.56% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.08% |
| Shareholder Yield | -23.08% |
| Earnings Yield | -27.90% |
| FCF Yield | -23.34% |
Analyst Forecast
The average price target for ADCT is $8.00, which is 112.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 112.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 30.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -7.59 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.59 |
| Piotroski F-Score | 4 |
